Innovation Authority selects two new Deep Tech incubators to focus on energy, infrastructure, and medical tech
Square One Labs Build and Edge Medical Ventures will each secure NIS 40 million over five years aimed at creating dozens of startups in energy, infrastructure, and medical technology.
The Israel Innovation Authority has announced the selection of two new Deep Tech incubators - Square One Labs Build and Edge Medical Ventures - aimed at creating dozens of startups in energy, infrastructure, and medical technology over the next five years.
Each incubator will receive up to NIS 40 million in government funding, with additional private investment expected to exceed NIS 120 million. The initiative is part of a new “Venture Creation & Building Studio” model that blends public and private capital to accelerate early-stage innovation in fields that require technological and financial commitment.
"This is a groundbreaking strategic move, based on insights and experience accumulated over years of operating previous incubator programs in Israel, combined with lessons learned from advanced global models—particularly from the United States,” said Dr. Alon Stopel, Chairman of the Israel Innovation Authority. “The process of designing the new program took many months and included precise adaptation to the evolving reality of the Israeli high-tech sector.”
Square One Labs Build will focus on startups in energy, advanced industry, and data center infrastructure. The incubator is backed by a consortium of Israeli corporations, including Doral Energy-Tech Ventures, Bazan Group, and Afcon. Using an ‘Entrepreneur-in-Residence’ model, the incubator will help entrepreneurs build solutions tailored to real industry needs, supported by four specialized labs in fields such as robotics and thermodynamics. Its leadership team includes Amir Fishlov and Yoav Galin (co-founders of SolarEdge), Yonatan Bik (CTO), and Miki Hefetz (VP of Business Development).
Edge Medical Ventures will specialize in medical devices and Bio-convergence, combining hardware, software, and biological sciences. It is backed by global and local entities, including Boston Scientific, Sheba Medical Center, and Cornell University Medical Center. The incubator will provide startups with clinical validation, prototype labs, in-vivo testing, and regulatory guidance. Its leadership team includes Shay Poliker (CEO), Gal Atarot (CTO), Noam Teichler (CFO), and Eileen Kee (VP of Commercialization).
“The selected incubators will serve as active creation engines, enabling the establishment of innovative companies from ideation or early research stage and supporting them throughout all stages of development—from inception to market entry and global growth,” added Dror Bin, CEO of the Israel Innovation Authority. “This model not only reduces the risk for entrepreneurs but also provides them with everything they need to truly succeed—access to advanced laboratories, strategic partnerships, expertise from leading institutions, and substantial government investment. We believe in the power of Deep Tech to be a game-changer in fields such as health, infrastructure, energy, and science—and the platforms selected today will serve as the launchpad for the next great Israeli success stories."
The selection of the incubators followed a competitive process launched in 2024, aligned with a new Startup Fund designed to support Deep Tech ventures from ideation to Series A - without taking equity or diluting founders.
